title: The protein kinase A inhibitor H89 acts on cell morphology by inhibiting Rho kinase.
abstract: The small GTPase RhoA can retract cell extensions by acting on two Rho kinases (ROCKs). Activated protein kinase A (PKA) inhibits RhoA and induces extensions. The isoquinoline H89 inhibits PKA and thus should prevent the inactivation of RhoA. In kinase assays, H89 has been recently found to inactivate a ROCK-II also. Because H89 may be able to exert opposite effects on cell extensions, we have studied the effects of H89 on neurite formation in the neuroblastoma-glioma line NG 108-15, which expresses ROCK-I and ROCK-II. We found that H89 can indeed inhibit ROCKs and PKA. Because ROCKs act downstream of RhoA, the inhibitory effect of H89 on ROCKs is most prominent. The data indicate that H89 may not be used as an antagonist of PKA in systems in which ROCKs play a role.
authors.affiliation: Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Albert-Ludwigs-Universität, Freiburg, Germany.
authors.forename: Jost
authors.initials: J
authors.lastname: Leemhuis
authors.forename: Stephanie
authors.initials: S
authors.lastname: Boutillier
authors.forename: Gudula
authors.initials: G
authors.lastname: Schmidt
authors.forename: Dieter K
authors.initials: DK
authors.lastname: Meyer
mesh_terms: D000577:Amides / Q000494:pharmacology; D015153:Blotting, Western; D017868:Cyclic AMP-Dependent Protein Kinases / Q000037:antagonists & inhibitors*; D003599:Cytoskeleton / Q000187:drug effects / Q000201:enzymology / Q000648:ultrastructure; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005822:Genetic Vectors; D006801:Humans; D007091:Image Processing, Computer-Assisted; D007150:Immunohistochemistry; D047908:Intracellular Signaling Peptides and Proteins; D007546:Isoquinolines / Q000494:pharmacology*; D018613:Microscopy, Confocal; D016501:Neurites / Q000187:drug effects / Q000201:enzymology / Q000648:ultrastructure; D009474:Neurons / Q000187:drug effects / Q000201:enzymology / Q000648:ultrastructure*; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors / Q000378:metabolism; D011725:Pyridines / Q000494:pharmacology; D013449:Sulfonamides; D014162:Transfection; D014407:Tumor Cells, Cultured; D054460:rho-Associated Kinases; D020742:rhoA GTP-Binding Protein / Q000037:antagonists & inhibitors*
chemical_list: D000577:Amides; D004791:Enzyme Inhibitors; D047908:Intracellular Signaling Peptides and Proteins; D007546:Isoquinolines; D011725:Pyridines; D013449:Sulfonamides; C108830:Y 27632; D017346:Protein Serine-Threonine Kinases; D054460:rho-Associated Kinases; D017868:Cyclic AMP-Dependent Protein Kinases; D020742:rhoA GTP-Binding Protein; C063509:N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide